Related Experiment Video
Updated: Mar 23, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential
Marta Fernandez-Mercado1, Lorea Manterola1, Charles H Lawrie2
1Oncology area, Biodonostia Research Institute, San Sebastián, Spain;
Abstract:
Although it is now evident that microRNAs (miRNAs) play a critical regulatory role in many, if not all, pathological and physiological processes, remarkably they have only formally been recognized for less than fifteen years. These endogenously produced short non-coding RNAs have created a new paradigm of gene control and have utility as both novel biomarkers of cancer and as potential therapeutics. In this review we consider the role of miRNAs in lymphoid biology both under physiological (i.e. lymphopoiesis) and malignant (i.e. lymphomagenesis) conditions. In addition to the functional significance of aberrant miRNA expression in lymphomas we discuss their use as novel biomarkers, both as a in situ tumour biomarker and as a non-invasive surrogate for the tumour by testing miRNAs in the blood of patients. Finally we consider the use of these molecules as potential therapeutic agents for lymphoma (and other cancer) patients and discuss some of the hurdles yet to be overcome in order to translate this potential into clinical practice.
Insights
MicroRNAs (miRNAs) are short non-coding RNAs regulating gene control, vital in lymphoid biology and cancer. This review explores their role in lymphopoiesis, lymphomagenesis, and potential as biomarkers and therapeutics.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are short, non-coding RNA molecules.
- They have emerged as critical regulators in physiological and pathological processes, including cancer.
- Their formal recognition is less than 15 years old.
Purpose of the Study:
- To review the role of miRNAs in lymphoid biology.
- To discuss miRNAs in lymphopoiesis and lymphomagenesis.
- To explore their utility as biomarkers and therapeutics for lymphoma.
Main Methods:
- Literature review focusing on miRNA function in lymphoid systems.
- Analysis of miRNA expression in physiological and malignant conditions.
- Examination of current and potential clinical applications.
Main Results:
- Aberrant miRNA expression is significant in lymphomas.
- miRNAs show potential as both in situ and non-invasive biomarkers.
- miRNAs are being investigated as therapeutic agents for lymphoma.
Conclusions:
- miRNAs represent a new paradigm in gene regulation.
- They hold significant promise as diagnostic biomarkers for lymphoma.
- Further research is needed to overcome hurdles for therapeutic translation in clinical practice.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation

